Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Pharmaxis Ltd ( (AU:SNT) ) just unveiled an announcement.
Syntara Limited reported its quarterly cash flow, showing positive net cash flow from financing activities amounting to A$11.352 million, driven by the proceeds from equity securities. Meanwhile, the company experienced a net cash inflow from investing activities of A$2.01 million, though operating activities resulted in a net cash outflow of A$337,000. The overall cash and cash equivalents increased by A$4.338 million during the quarter, indicating strong financial management and positioning.
More about Pharmaxis Ltd
YTD Price Performance: -11.25%
Average Trading Volume: 4,998,478
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$112.1M
See more insights into SNT stock on TipRanks’ Stock Analysis page.
